Table 2.
Clinical data of patients with focal-type autoimmune pancreatitis (AIP) and pancreatic duct carcinoma (PD)
Focal-type AIP n = 20 (± SD) |
PD n = 30 (± SD) |
p | |
---|---|---|---|
Age (y) | 65.25 ± 9.40 | 66.87 ± 8.45 | 0.539 |
Male/Female | 11/9 | 18/12 | 0.953 |
Lesion size (mm) | 33.54 ± 13.62 | 26.96 ± 7.78 | 0.061 |
IgG4 > 280 (mg/dl) | 8 | ||
280≧IgG4≧135 (mg/dl) | 7 | ||
Narrowing of main pancratic duct on ERP/MRCP | 18 | ||
Pathological findings | 9 | ||
Other organ involvement | 6 | ||
Effectiveness of steroid therapy | 15 | ||
cT Stagea | |||
T1a | 0 | ||
T1b | 0 | ||
T1c | 8 | ||
T2 | 22 | ||
T3 | 0 | ||
T4 | 0 |
ERP endoscopic retrograde pancreatography, MRCP magnetic resonance cholangiopancreatography
aAccording to the 8th edition of the TNM classification of malignant tumors